3 ms·
> Let me flip it around the other way: because many people were not casually poisoned due to laws about drug safety, aerosolized lead and lead paint chips, food
by AnthonyMouse 7y ago
> Let me flip it around the other way: because many people were not casually poisoned due to laws about drug safety, aerosolized lead and lead paint chips, food safety, seat belts etc there are more people around today to develop new things.
That doesn't flip it around at all, it's still the same problem. There is a trade off between costing lives by being too reckless and costing lives by being too conservative. Your argument in fact exacerbates the problem of being too conservative -- of being too far away from the optimal trade off in either direction -- because it applies just as much to the lives lost to slower progress.
And banning lead or similar is a completely different situation because the data is in on lead. It's not prohibited because we don't know if it's bad for you or not, it's prohibited because we do know that it's very bad for you with a high degree of confidence. It's obvious what to do with things that are well known, the question is what to do with things that are not.
> A test that has not been characterized and qualified produces unknown results
Known and unknown are not binary states. You can have a new test which is more likely to work than not based on all currently available evidence and you have to choose whether to use it during the period when better data is being gathered. The best answer is not automatically no.
That is different than the problem for approvals in general, but still the same. In the normal case you have to choose whether less rigorous use is allowed in early stages which provides more data prior to making the decision of whether to even do the more expensive more rigorous trials, thereby making the rigorous trials that are actually performed more likely to have positive results and increasing the number of effective treatments on the market.